Literature DB >> 19775393

Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.

Michi M Shinohara1, Evan George.   

Abstract

We report a case of cutaneous Scedosporium apiospermum infection in an immunocompromised host. S.apiospermum is an emerging opportunistic pathogen, especially in organ transplant recipients. Prompt identification is critical because of its resistance to most antifungal drugs. Its histopathologic features are indistinct and overlap with those of more commonly recognized hyalohyphomycetes such as Aspergillus species. Cultures from infected tissue are generally required for correct identification. Clinicians and pathologists must be familiar with this organism and recognize the need for culture studies in addition to histopathology in the evaluation of specimens from immunocompromised patients with suspected fungal infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775393     DOI: 10.1111/j.1600-0560.2008.01208.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Prompt diagnosis of Scedosporium apiospermum soft tissue infection: Life-saving in a renal transplant recipient.

Authors:  R Ghosh; P Mishra; P K Maiti; A Debnandi
Journal:  J Postgrad Med       Date:  2017 Jul-Sep       Impact factor: 1.476

Review 2.  Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.

Authors:  Lucie Peyclit; Hanane Yousfi; Jean-Marc Rolain; Fadi Bittar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20

3.  Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature.

Authors:  Chloe Goldman; Matthew J Akiyama; Julian Torres; Eddie Louie; Shane A Meehan
Journal:  Med Mycol Case Rep       Date:  2016-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.